In one investigation, AdVs were employed as a therapeutic tool for purging MM cells, showing their ability to deliver the TK gene into MM cells using the DF3/MUC1 tumor promoter, with tumor cell transduction observed to be highly efficient (>80%) (34). This evidence concerns the gene MUC1 and Miyoshi myopathy.